Genomics & biotech innovation (ARK).
Covered positions by weight, as of 2026-04-30. Each links to its stock page and our full verdict.
| # | Holding | Our call | % of NAV | Value |
|---|---|---|---|---|
| 1 | TEM | Hold | 9.42% | $116M |
| 2 | TWST | Hold | 8.99% | $111M |
| 3 | CRSP | Hold | 8.91% | $110M |
| 4 | TXG | Hold | 5.77% | $71.3M |
| 5 | BEAM | — | 5.43% | $67.1M |
| 6 | ABSI | — | 4.78% | $59.1M |
| 7 | NTRA | Hold | 4.07% | $50.2M |
| 8 | ILMN | Hold | 4.03% | $49.8M |
| 9 | NTLA | — | 3.82% | $47.2M |
| 10 | PSNL | — | 3.58% | $44.3M |
| 11 | RXRX | — | 3.51% | $43.4M |
| 12 | GH | Hold | 3.49% | $43.2M |
| 13 | CDNA | — | 3.38% | $41.8M |
| 14 | VCYT | Hold | 2.66% | $32.9M |
| 15 | CMPS | — | 2.43% | $30.0M |
| 16 | ADPT | — | 2.42% | $29.9M |
| 17 | NRIX | — | 2.33% | $28.8M |
| 18 | WGS | — | 2.04% | $25.2M |
| 19 | SDGR | — | 2.03% | $25.0M |
| 20 | ARCT | — | 1.96% | $24.2M |
| 21 | BFLY | — | 1.89% | $23.4M |
| 22 | IONS | Buy | 1.74% | $21.5M |
| 23 | ATAI | — | 1.48% | $18.2M |
| 24 | PRME | — | 1.41% | $17.5M |
| 25 | PACB | — | 1.41% | $17.4M |
| 26 | CERS | — | 1.22% | $15.1M |
| 27 | ALMR | — | 1.21% | $14.9M |
| 28 | MASS | — | 1.08% | $13.3M |
| 29 | BNTX | — | 1.06% | $13.1M |
| 30 | LLY | Buy | 0.95% | $11.7M |
| 31 | QSI | — | 0.55% | $6.79M |
| 32 | GENB | — | 0.51% | $6.36M |
| 33 | FTOXX | — | 0.13% | $1.58M |
Source: SEC Form N-PORT-P (the fund’s latest public fiscal-quarter-end report, filed ~2 months after the period). Weights and values are as reported in the filing — a delayed snapshot, not a live book. Positions are resolved to tickers via the filing’s identifiers and CUSIP mapping; unresolved lines are excluded. “Our call” is TENK/calls’s independent SEC-grounded verdict, not the fund’s view. No market-price data is used on this page.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.